Literature DB >> 21353276

Infection of primary human tonsillar lymphoid cells by KSHV reveals frequent but abortive infection of T cells.

Jinjong Myoung1, Don Ganem.   

Abstract

The lymphotropic herpesvirus KSHV principally infects B cells in vivo and is linked to several human B cell lymphoproliferative syndromes. Here we examine the susceptibility of primary tonsillar lymphocytes to infection by a recombinant KSHV (rKSHV.219) that constitutively expresses GFP. At an MOI of ~1, ca. 5-10% of CD19+ B cells became GFP-positive. Surprisingly, in the same culture many more T cells became infected. However, in contrast to isolated B cells, isolated infected T cells did not support correct viral transcription and did not produce infectious virus, indicating the presence of one or more post-entry blocks to lytic KSHV replication in T cells. No immortalization or transformation has yet been observed in either B or T cells. These results affirm the feasibility of studying KSHV infection in primary lymphoid cells, and help to rationalize the detection of KSHV DNA in rare human T cell lymphomas in vivo.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21353276      PMCID: PMC3070441          DOI: 10.1016/j.virol.2010.12.036

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  66 in total

1.  Cohesins localize with CTCF at the KSHV latency control region and at cellular c-myc and H19/Igf2 insulators.

Authors:  William Stedman; Hyojeung Kang; Shu Lin; Joseph L Kissil; Marisa S Bartolomei; Paul M Lieberman
Journal:  EMBO J       Date:  2008-01-24       Impact factor: 11.598

2.  Transcriptional activation by EBV nuclear antigen 1 is essential for the expression of EBV's transforming genes.

Authors:  Markus Altmann; Dagmar Pich; Romana Ruiss; Jindong Wang; Bill Sugden; Wolfgang Hammerschmidt
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-11       Impact factor: 11.205

Review 3.  KSHV/HHV8-associated lymphomas.

Authors:  Antonino Carbone; Annunziata Gloghini
Journal:  Br J Haematol       Date:  2007-11-07       Impact factor: 6.998

4.  KSHV/HHV-8 infection of human hematopoietic progenitor (CD34+) cells: persistence of infection during hematopoiesis in vitro and in vivo.

Authors:  William Wu; Jeffrey Vieira; Nancy Fiore; Prabal Banerjee; Michelle Sieburg; Rosemary Rochford; William Harrington; Gerold Feuer
Journal:  Blood       Date:  2006-03-16       Impact factor: 22.113

Review 5.  KSHV infection and the pathogenesis of Kaposi's sarcoma.

Authors:  Don Ganem
Journal:  Annu Rev Pathol       Date:  2006       Impact factor: 23.472

6.  c-Myc and Rel/NF-kappaB are the two master transcriptional systems activated in the latency III program of Epstein-Barr virus-immortalized B cells.

Authors:  Nathalie Faumont; Stéphanie Durand-Panteix; Martin Schlee; Sebastian Grömminger; Marino Schuhmacher; Michael Hölzel; Gerhard Laux; Reinhard Mailhammer; Andreas Rosenwald; Louis M Staudt; Georg W Bornkamm; Jean Feuillard
Journal:  J Virol       Date:  2009-03-04       Impact factor: 5.103

7.  Human herpesvirus 8 infects and replicates in primary cultures of activated B lymphocytes through DC-SIGN.

Authors:  Giovanna Rappocciolo; Heather R Hensler; Mariel Jais; Todd A Reinhart; Amarendra Pegu; Frank J Jenkins; Charles R Rinaldo
Journal:  J Virol       Date:  2008-03-12       Impact factor: 5.103

8.  Cell cycle control of Kaposi's sarcoma-associated herpesvirus latency transcription by CTCF-cohesin interactions.

Authors:  Hyojeung Kang; Paul M Lieberman
Journal:  J Virol       Date:  2009-04-15       Impact factor: 5.103

9.  Effects of NFkappaB activation on KSHV latency and lytic reactivation are complex and context-dependent.

Authors:  Claudia Grossmann; Don Ganem
Journal:  Virology       Date:  2008-03-05       Impact factor: 3.616

10.  Tonsilar NK cells restrict B cell transformation by the Epstein-Barr virus via IFN-gamma.

Authors:  Till Strowig; Fabienne Brilot; Frida Arrey; Gwenola Bougras; Dolca Thomas; William A Muller; Christian Münz
Journal:  PLoS Pathog       Date:  2008-02-08       Impact factor: 6.823

View more
  38 in total

1.  KSHV infection of B-cell lymphoma using a modified KSHV BAC36 and coculturing system.

Authors:  Hyosun Cho; Hyojeung Kang
Journal:  J Microbiol       Date:  2012-04-27       Impact factor: 3.422

2.  Kaposi's sarcoma-associated herpesvirus-encoded microRNA miR-K12-11 attenuates transforming growth factor beta signaling through suppression of SMAD5.

Authors:  Yunhua Liu; Rui Sun; Xianzhi Lin; Deguang Liang; Qiang Deng; Ke Lan
Journal:  J Virol       Date:  2011-10-19       Impact factor: 5.103

3.  Active lytic infection of human primary tonsillar B cells by KSHV and its noncytolytic control by activated CD4+ T cells.

Authors:  Jinjong Myoung; Don Ganem
Journal:  J Clin Invest       Date:  2011-02-21       Impact factor: 14.808

4.  Generation of a doxycycline-inducible KSHV producer cell line of endothelial origin: maintenance of tight latency with efficient reactivation upon induction.

Authors:  Jinjong Myoung; Don Ganem
Journal:  J Virol Methods       Date:  2011-03-17       Impact factor: 2.014

5.  K1 and K15 of Kaposi's Sarcoma-Associated Herpesvirus Are Partial Functional Homologues of Latent Membrane Protein 2A of Epstein-Barr Virus.

Authors:  Lisa Steinbrück; Montse Gustems; Stephanie Medele; Thomas F Schulz; Dominik Lutter; Wolfgang Hammerschmidt
Journal:  J Virol       Date:  2015-05-06       Impact factor: 5.103

6.  Comment on primary lymphocyte infection models for KSHV and its putative tumorigenesis mechanisms in B cell lymphomas (Journal of Microbiology 2017, 55(5): 319-329).

Authors:  Giovanna Rappocciolo; Frank Jenkins; Charles R Rinaldo
Journal:  J Microbiol       Date:  2017-07       Impact factor: 3.422

Review 7.  Kaposi sarcoma-associated herpesvirus: immunobiology, oncogenesis, and therapy.

Authors:  Dirk P Dittmer; Blossom Damania
Journal:  J Clin Invest       Date:  2016-09-01       Impact factor: 14.808

Review 8.  Recent advances in the study of Kaposi's sarcoma-associated herpesvirus replication and pathogenesis.

Authors:  Denis Avey; Brittany Brewers; Fanxiu Zhu
Journal:  Virol Sin       Date:  2015-04-23       Impact factor: 4.327

Review 9.  Viral interleukin-6: role in Kaposi's sarcoma-associated herpesvirus: associated malignancies.

Authors:  Shuhei Sakakibara; Giovanna Tosato
Journal:  J Interferon Cytokine Res       Date:  2011-07-18       Impact factor: 2.607

10.  A unique herpesviral transcriptional program in KSHV-infected lymphatic endothelial cells leads to mTORC1 activation and rapamycin sensitivity.

Authors:  Henry H Chang; Don Ganem
Journal:  Cell Host Microbe       Date:  2013-04-17       Impact factor: 21.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.